Skip to main content
MIT Corporate Relations
MIT Corporate Relations
Search
×
Read
Watch
Attend
About
Connect
MIT Startup Exchange
Search
Sign-In
Register
Search
×
MIT ILP Home
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
User Menu and Search
Search
Sign-In
Register
MIT ILP Home
Toggle menu
Search
Sign-in
Register
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
4.12.22-Health-Science-Deepak-Mishra
Conference Video
|
Duration: 37:37
April 12, 2022
View this past event
Preview
4.12.22-Health-Science-Deepak-Mishra
Please
login
to view this video.
Video details
Organoids are tiny, self-organized three-dimensional (3D) tissue cultures erived from stem cells that allow recapitulation of architecture, composition, and physiology of organs. Organoids may be formed by combining individually differentiated cell populations or via the introduction of external cues to human induced pluripotent stem cells (hiPSCs) to mimic stages of human development. However, such approaches may limit intercellular interactions or faithful mimicry of a mature organ’s structure. We employ synthetic gene circuits to genetically engineer human induced pluripotent stem cells (hIPSCs) with transcriptional and post-transcriptional regulatory elements. These networks govern multi-step differentiation of hiPSCs in a cell-specific, semi-automated manner to form 3D liver organoids. Our recent advances in creation and subsequent use of these organoids in toxicology, drug metabolism, and implantation will be presented and discussed.
Locked Interactive transcript
Please
login
to view this video.
Video details
Organoids are tiny, self-organized three-dimensional (3D) tissue cultures erived from stem cells that allow recapitulation of architecture, composition, and physiology of organs. Organoids may be formed by combining individually differentiated cell populations or via the introduction of external cues to human induced pluripotent stem cells (hiPSCs) to mimic stages of human development. However, such approaches may limit intercellular interactions or faithful mimicry of a mature organ’s structure. We employ synthetic gene circuits to genetically engineer human induced pluripotent stem cells (hIPSCs) with transcriptional and post-transcriptional regulatory elements. These networks govern multi-step differentiation of hiPSCs in a cell-specific, semi-automated manner to form 3D liver organoids. Our recent advances in creation and subsequent use of these organoids in toxicology, drug metabolism, and implantation will be presented and discussed.
Locked Interactive transcript
More Videos From This Event
See all videos
April 2022
|
Conference Video
4.12.22-Health-Science-Eric-Smith
DFCI: The Challenges and Opportunities in Cell and Gene Therapy
April 2022
|
Conference Video
4.12.22-Health-Science-Ran-Zheng
Unlocking the Potential of Life Sciences Innovation by Harnessing the Power of Mission-driven Collaborations
April 2022
|
Conference Video
4.12.22-Health-Science-Parisa-Yousefpour
Self-Replicating RNA Technologies for Vaccines and Cancer Immunotherapy
April 2022
|
Conference Video
4.12.22-Health-Science-Jongyoon-Han
Label-Free Biophysical Critical Quality Attributes (CQAs) for Cell Therapy Products
April 2022
|
Conference Video
4.12.22-Health-Science-Feng Zhang
Exploration of Biological Diversity
April 2022
|
Conference Video
4.12.22-Health-Science-Jianzhu-Chen
CAR-NK Cell Therapies for Cancer
April 2022
|
Conference Video
4.12.22-Health-Science-Braatz-Nguyen
Rational Design of rAAV Production via Mechanistic Modeling
April 2022
|
Conference Video
4.12.22-Health-Science-Michael-Birnbaum
Reprogramming adaptive immunity
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Kytopen
Kytopen
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Cellino
Cellino
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Tevard-Biosciences
Tevard Biosciences
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Multiply-Labs
Multiply Labs
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Kano-Therapeutics
Kano Therapeutics
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Volta-Labs
Volta Labs
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-CellChorus
CellChorus
April 2022
|
Conference Video
4.12.22-Health-Science-Startups-Fathom-Data
Fathom Data